Your browser doesn't support javascript.
loading
Multimeric single-domain antibody complexes protect against bunyavirus infections.
Wichgers Schreur, Paul J; van de Water, Sandra; Harmsen, Michiel; Bermúdez-Méndez, Erick; Drabek, Dubravka; Grosveld, Frank; Wernike, Kerstin; Beer, Martin; Aebischer, Andrea; Daramola, Olalekan; Rodriguez Conde, Sara; Brennan, Karen; Kozub, Dorota; Søndergaard Kristiansen, Maiken; Mistry, Kieran K; Deng, Ziyan; Hellert, Jan; Guardado-Calvo, Pablo; Rey, Félix A; van Keulen, Lucien; Kortekaas, Jeroen.
Afiliação
  • Wichgers Schreur PJ; Department of Virology, Wageningen Bioveterinary Research, Lelystad, Netherlands.
  • van de Water S; Department of Virology, Wageningen Bioveterinary Research, Lelystad, Netherlands.
  • Harmsen M; Department of Virology, Wageningen Bioveterinary Research, Lelystad, Netherlands.
  • Bermúdez-Méndez E; Department of Virology, Wageningen Bioveterinary Research, Lelystad, Netherlands.
  • Drabek D; Laboratory of Virology, Wageningen University, Wageningen, Netherlands.
  • Grosveld F; Department of Cell Biology, Erasmus MC, Rotterdam, Netherlands.
  • Wernike K; Harbour Antibodies B.V, Rotterdam, Netherlands.
  • Beer M; Department of Cell Biology, Erasmus MC, Rotterdam, Netherlands.
  • Aebischer A; Harbour Antibodies B.V, Rotterdam, Netherlands.
  • Daramola O; Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald - Insel Riems, Germany.
  • Rodriguez Conde S; Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald - Insel Riems, Germany.
  • Brennan K; Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald - Insel Riems, Germany.
  • Kozub D; Biopharmaceutical Development, R&D BioPharmaceuticals, AstraZeneca, Cambridge, United Kingdom.
  • Søndergaard Kristiansen M; Biopharmaceutical Development, R&D BioPharmaceuticals, AstraZeneca, Cambridge, United Kingdom.
  • Mistry KK; Biopharmaceutical Development, R&D BioPharmaceuticals, AstraZeneca, Cambridge, United Kingdom.
  • Deng Z; Biopharmaceutical Development, R&D BioPharmaceuticals, AstraZeneca, Cambridge, United Kingdom.
  • Hellert J; Biopharmaceutical Development, R&D BioPharmaceuticals, AstraZeneca, Cambridge, United Kingdom.
  • Guardado-Calvo P; Biopharmaceutical Development, R&D BioPharmaceuticals, AstraZeneca, Cambridge, United Kingdom.
  • Rey FA; Biopharmaceutical Development, R&D BioPharmaceuticals, AstraZeneca, Cambridge, United Kingdom.
  • van Keulen L; Structural Virology Unit, Virology Department, CNRS UMR 3569, Institut Pasteur, Paris, France.
  • Kortekaas J; Structural Virology Unit, Virology Department, CNRS UMR 3569, Institut Pasteur, Paris, France.
Elife ; 92020 04 21.
Article em En | MEDLINE | ID: mdl-32314955
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Infecções por Bunyaviridae / Anticorpos de Domínio Único Limite: Animals / Female / Humans / Male Idioma: En Revista: Elife Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Infecções por Bunyaviridae / Anticorpos de Domínio Único Limite: Animals / Female / Humans / Male Idioma: En Revista: Elife Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda